1/1
2 files

Fixed Dose of Cemiplimab in Patients with Advanced Malignancies based on Population Pharmacokinetic Analysis

figure
posted on 04.03.2021, 17:38 by Adis journals on behalf of, Anne J. Paccaly, Michael R. Migden, Kyriakos P. Papadopoulos, Feng Yang, John D. Davis, Ronda K. Rippley, Israel Lowy, Matthew G. Fury, Elizabeth Stankevich, Danny Rischin

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History